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Human and simian immunodeficiency viruses (HIV/SIV) exhibit enormous sequence heterogeneity within
each infected host. Here, we use ultradeep pyrosequencing to create a comprehensive picture of CD8
T-lymphocyte (CD8-TL) escape in SIV-infected macaques, revealing a previously undetected complex pattern
of viral variants. This increased sensitivity enabled the detection of acute CD8-TL escape as early as 17 days
postinfection, representing the earliest published example of CD8-TL escape in intrarectally infected ma-
caques. These data demonstrate that pyrosequencing can be used to study the evolution of CD8-TL escape
during immunodeficiency virus infection with an unprecedented degree of sensitivity.
Rapid sequence evolution is a hallmark of immunodefi-
ciency virus infection and represents a major obstacle toward
the development of a successful human immunodeficiency vi-
rus (HIV) vaccine (2, 3). Viral evolution has implications for
HIV treatment and provides critical information about host
immune responses. Although the viral population contains an
enormous amount of sequence diversity, standard sequencing
methods are limited to the detection of high-frequency vari-
ants. Techniques that permit characterization of rare variants,
such as molecular cloning, single-genome amplification, or
quantitative RT-PCR, are either labor intensive or restricted
to the detection of a single variant, limiting their widespread
use (9, 11, 12, 18). As a result, the functional consequences of
low-frequency variants and subtle differences in the kinetics of
viral evolution are not well understood.
CD8 T lymphocytes (CD8-TL) play a critical role in the sup-
pression of immunodeficiency viruses and are a driving force in
HIV/SIV (simian immunodeficiency virus) viral evolution (7, 8,
15, 20). Because the emergence of escape mutations within
CD8-TL epitopes alters the recognition of infected cells, moni-
toring viral variation within epitopes has important implications
(10, 16). Due to the sequencing limitations noted above, studies of
CD8-TL escape are generally limited to the detection of high-
frequency variants. As a result, CD8-TL escape is frequently
viewed as a binary event: an epitope is either wild type or escaped.
In this study, we applied ultradeep pyrosequencing to eval-
uate acute CD8-TL escape in SIV-infected macaques. We val-
idated this method by sequencing the Tat28-35SL8 (SL8)
epitope in eight Indian rhesus macaques, demonstrating the
ability to detect amino acid variants with a frequency as low as
1%. We then examined Nef103-111RM9 (RM9) viral escape in
four Mauritian cynomolgus macaques (MCMs), demonstrating
that viral escape within RM9 occurs as early as 17 days postin-
fection. Pyrosequencing detected a considerable heterogeneity
in the diversity, frequency, and kinetics of viral variation be-
tween animals that was undetectable by conventional methods.
This exceptional variability is present in the viral population
until at least 20 weeks postinfection. These studies demon-
strate that ultradeep pyrosequencing is a high-throughput
method that can be used to sensitively detect and characterize
CD8-TL escape variants in any given epitope.
Ultradeep pyrosequencing of Tat28-35SL8 in SIV-infected
Indian rhesus macaques. We initially applied pyrosequencing
to study SIVmac239 escape in the well-characterized Mamu-
A1*001-restricted epitope Tat28-35SL8 (SL8) (note: following
revisions in macaque major histocompatibility complex [MHC]
nomenclature, the allele formerly published as Mamu-A*01
will be referred to as Mamu-A1*001 [19]). Viral RNA samples
from four SIV-infected, Mamu-A1*001-positive and four SIV-
infected, Mamu-A1*001-negative animals were isolated from
plasma at weeks 1, 2, 3, 4, 8, and 20 postinfection. Three of the
Mamu-A1*001-positive animals (rh2122, rh2126, and rh2127)
were vaccinated with a DNA prime/recombinant modified vac-
cinia virus Ankara regimen prior to intrarectal SIVmac239
* Corresponding author. Mailing address: University of Wisconsin—
Madison, 555 Science Drive, Madison, Wisconsin 53711. Phone: (608)
890-0845. Fax: (608) 265-8084. E-mail: doconnor@primate.wisc.edu.
† Supplemental material for this article may be found at http://jvi
.asm.org/.
‡ These authors contributed equally to the manuscript.
 Published ahead of print on 10 June 2009.
8247
 o
n
 February 25, 2014 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
FIG. 1. Sequencing of Tat28-35SL8 in rhesus macaques. The Tat28-35SL8 regions from four Mamu-A1*001-positive rhesus macaques were sequenced using
both pyrosequencing and conventional Sanger sequencing. (A) Consensus sequence from each sample with any change indicated as X. The pyrosequencing
consensus (left) contains any mutation present in 1% or more of the total reads. Nonsynonymous and synonymous mutations are colored according to
prevalence, indicated by the color key in the upper right. The consensus sequence obtained from conventional Sanger sequencing is displayed on the right.
(B) Pyrosequencing consensus sequence from a Mamu-A1*001-negative animal, showing all mutations present at greater than 1%. (C) Percentage of each
variant observed by pyrosequencing at day 21 within Tat28-35SL8. Only variants present at 1% or greater in at least one animal are shown. All other variants are
expressed as “Other.” Dashes indicate that a variant was not present in that sample. (D) Similar to panel C, showing variants at week 20.
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FIG. 2. Sequencing of Nef103-111RM9 in MCMs. The Nef103-111RM9 regions from four Mafa-A1*063-positive MCMs were sequenced using both
pyrosequencing and conventional Sanger sequencing. A SIVmac239 inoculum was also sequenced by pyrosequencing. (A) Consensus sequence from each
sample with any change indicated as X. The pyrosequencing consensus (left) contains any mutation present in 1% or more of total sequence reads. An
average of 1,008 reads was obtained for each sample, with greater than 350 reads obtained from all samples except for cy0161 at day 17 (203 reads) and
cy0162 at week 20 (237 reads). Nonsynonymous and synonymous mutations are colored according to prevalence, indicated by the color key in the upper
right. The consensus sequence obtained from conventional Sanger sequencing is displayed on the right. (B) Percentage of each variant observed by
pyrosequencing at day 17 within Nef103-111RM9. Only variants present at 1% or greater in at least one animal are shown. All other variants are expressed
as “Other.” Dashes indicate that a variant was not present in that sample. (C) Similar to panel B, showing variants at week 20.
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infection (21). The generation and pyrosequencing of RT-PCR
amplicons is described in detail in the methods section of the
supplemental material. Previous studies using pyrosequencing
to study HIV drug resistance have demonstrated that approx-
imately 400 reads are needed to detect nucleotide variants at a
frequency of greater than 1% in nonhomopolymeric regions
(22). We obtained an average of 1,707 reads per sample, with
a minimum of 455. Therefore, we are likely able to detect most
of the major amino acid variants in each sample.
Figure 1A contains the consensus sequence of each sam-
ple, showing positions with mutations present in greater
than 1% of the viral population. The pattern of mutation is
more comprehensive than that obtained by conventional
Sanger sequencing of bulk PCR products (Fig. 1A). While it
is not currently known at what threshold a low-frequency
mutation should be considered biologically relevant, it is
worth noting that of the amino acid mutations not detected
by conventional Sanger sequencing, 22 were present in 10%
or more of the population. We observed variation within
SL8 in all Mamu-A1*001-positive animals by day 21, with
low-frequency variants appearing at day 14 in two of four
animals. The kinetics of escape are consistent with previ-
ously published findings using Sanger sequencing of bulk
PCR products or individual viral clones (1, 13, 16). To
ensure the accuracy of this technique, we included multiple
controls. As might be expected, we did not observe any
mutations at week 1, except for a single low-frequency syn-
onymous mutation in rh2124. Further, there was a signifi-
cant decrease in the frequency of mutations observed in the
region flanking the SL8 epitope compared with the number
of mutations within the epitope (see Table S2 in the sup-
plemental material). As a control, we sequenced the same
region from the SIVmac239 inoculum and from four SIV-
infected Mamu-A1*001-negative rhesus macaques (Fig. 1B
and Fig. S1 in the supplemental material). Neither the in-
oculum nor the Mamu-A1*001-negative macaques had de-
tectable mutations in the SL8 epitope. Together, these data
strongly suggest that the variation we observed is a direct
consequence of CD8-TL pressure and that pyrosequencing
can accurately detect mutations present with a frequency as
low as 1%.
Unlike conventional sequencing of bulk PCR products,
pyrosequencing provides clonal sequences, enabling the
characterization of individual variants (Fig. 1C and D; also
see Tables S3 to S6 in the supplemental material). A total of
13 distinct sequence variants were observed in SL8 at day 21
(Fig. 1C). Interestingly, there was considerable heterogeneity in
both the diversity and frequency of variants among the Mamu-
A1*001-positive animals, continuing to at least 20 weeks postin-
fection (Fig. 1D). Thus, we demonstrate that even though a mu-
tation may appear fixed by Sanger sequencing, extensive
variability can remain within the viral population. These differ-
ences in the timing, pattern, and frequency of viral variants may
influence disease outcome, yet they are rarely studied because
existing methods for examining this variation are extremely labor
intensive.
Ultradeep pyrosequencing of Nef103-111RM9 in SIV-infected
MCMs. We next used pyrosequencing to examine viral es-
cape in a group of four MCMs. Unlike the rhesus macaques
in the previous section, all MCMs were unvaccinated and
infected intrarectally with 50,000 50% tissue culture infec-
tious doses of SIVmac239. Using methods similar to our SL8
analysis, we prepared and sequenced RT-PCR amplicons
spanning the Mafa-A1*063-restricted epitope Nef103-111RM9
(RM9) (4) (see Table S1 in the supplemental material). Fol-
lowing revised nomenclature, the allele formerly published as
Mafa-A*25 will be referred to as Mafa-A1*063.
As with SL8, we found considerable heterogeneity in pat-
terns of viral variation within the RM9 epitope (Fig. 2A;
also see Tables S7 to S11 in the supplemental material).
Remarkably, we detected amino acid variation within RM9
by 17 days postinfection in all four MCMs. The majority of
these sequence variants represent less than 20% of the viral
population (Fig. 2B) (17). More than 50% of the sequences
obtained from CY0162 at 17 days postinfection contained
one or more variant amino acids within this epitope (Fig.
2C). These data imply that CD8-TL selection occurs as early
as 17 days postinfection. While CD8-TL escape mutations
have been detected in SL8 between 13 and 20 days after
intravenous SIV infection (13), the appearance of viral vari-
ants earlier than 3 weeks after intrarectal SIV infection in
unvaccinated animals has not yet been reported. Unlike the
case with Tat SL8, there was a considerable number of
low-frequency mutations in the region flanking RM9. Be-
cause SIVmac239 was isolated following passage through
rhesus macaques, we cannot rule out the hypothesis that
these mutations represent species-specific viral adaptations.
All four MCMs expressed Mafa-A1*063, so we also cannot
rule out the possibility that this adaptation is MHC specific.
However, it is worth noting that unlike RM9, Tat SL8 is
located within the overlapping reading frames of Tat and
Vpr. Therefore, one might hypothesize that mutations
within SL8 are more likely to result in loss of fitness, de-
creasing the plasticity of this region (6).
Tetramer analysis of Nef103-111RM9-specific CD8-TL. We
measured the frequency of peripheral RM9-specific
CD8-TL to confirm that the expansion of this population
was associated with the appearance of viral variants. Frozen
peripheral blood mononuclear cell samples from each ani-
mal were simultaneously thawed and stained with the MHC
FIG. 3. Data represent the percentage of tetramer-positive cells
within the CD3 CD8 cell gate. The limit of detection was 0.02% as
determined by day 0 postinfection tetramer staining.
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class I tetramer Mafa-A1*063 Nef RM9-APC, CD8-PerCP,
and CD3-FITC. In all four MCMs, we identified tetramer-
positive CD8-TL in the periphery beginning at 14 days
postinfection (Fig. 3), comparable to the kinetics of an SL8
CD8-TL response (1, 14). These data strongly support our
pyrosequencing results and suggest that selective pressure
exerted by SIVmac239-specific CD8-TL leads to variation
within RM9.
FIG. 4. Sequencing of Gag181-189CM9 in Indian rhesus macaques. The Gag181-189CM9 region from four Mamu-A1*001-positive Indian rhesus
macaques was sequenced by pyrosequencing. (A) Consensus sequence from each sample with any change indicated as X. The pyrosequencing consensus
(left) contains any mutation present in 1% or more of total reads. Nonsynonymous and synonymous mutations are colored according to prevalence,
indicated by the color key in the upper right. (B) Pyrosequencing consensus sequence from four Mamu-A1*001-negative animals and a SIVmac239
inoculum, showing all mutations present at greater than 1%. (C) Percentage of each variant observed by pyrosequencing at week 32 within Gag181-
189CM9. Only variants present at 1% or greater in at least one animal are shown. All other variants are expressed as “Other.” Dashes indicate that a
variant was not present in that sample. (D) Similar to panel C, showing variants at week 57. (E) Table showing the linkage between Gag181-189CM9
variants and known compensatory mutations at amino acid positions 161 and 206 for animal rh2122. (F) Similar to panel E, showing data for rh2127.
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Ultradeep pyrosequencing of Gag181-189CM9 in SIV-infected
Indian rhesus macaques. Next we examined viral escape within
Gag181-189CM9 (CM9), a well-characterized Mamu-A1*001-re-
stricted epitope that generally does not escape until chronic in-
fection (5). By week 57, we only observed CM9 escape in rh2122
and rh2127 (Fig. 4A). Examination of variant frequency revealed
CM9 mutation by week 32 in rh2127; however, the wild-type
sequence remained dominant through week 57 (Fig. 4C and D).
In contrast, no CM9 mutation was observed in rh2122 until after
week 32; however, a variant containing C181G comprised 96.6%
of the population by week 57 (Fig. 4C and D).
Several compensatory mutations have been associated
with CM9 escape, including I161V and I206V (5, 23). Vari-
ants with I161V were not observed in any animal (data not
shown). In rh2122, 95.1% of variants with C181G also con-
tained I206V (Fig. 4E). In contrast, I206V is never observed
in rh2127, an animal in which escape variants never com-
prise more than 50% of the population; however, we cannot
rule out the existence of additional compensatory mutations
outside this amplicon (Fig. 4F). For additional sequence
data from weeks 4 and 8, see Tables S12 and S13 in the
supplemental material.
Application of ultradeep pyrosequencing to the entire SIV
genome. With the success of sequencing individual amplicons,
we tested whether this method could be applied to the entire
viral genome. We designed 32 overlapping amplicons of ap-
proximately 400 bp each, spanning SIVmac239 from nucleo-
tides 1077 to 10267 (see Table S14 in the supplemental mate-
rial). We then performed RT-PCR on RNA isolated from a
SIVmac239 stock. These overlapping reads were assembled to
produce an average of 562-fold coverage at each nucleotide
position, although coverage was variable across the genome
(see Fig. S2A in the supplemental material). Within the coding
regions, we detected only nine point mutations present in 1%
or greater of the viral population, with no mutation present at
greater than 1.6% (see Fig. S2B in the supplemental material).
These results demonstrate that ultradeep pyrosequencing of
amplicons can be applied to sequencing the entire SIV genome
and represent the most rigorous characterization of the homo-
geneity of a SIVmac239 stock.
The data presented here demonstrate exceptional complex-
ity within SIV epitopes recognized by CD8-TL using ultradeep
pyrosequencing. The ability to readily identify and quantify
viral variants should permit unprecedented assessment of vari-
ant ontogeny, allowing a more nuanced view of the selection,
reversion, and potential fitness of variants that arise during
HIV/SIV infection.
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